Trial Summary
What is the purpose of this trial?The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care.
The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To achieve the specific aims, the investigators will conduct a randomized clinical trial (n = 270), with two treatment arms: ABBT vs. an attention-matched HIV education control condition.
Eligibility Criteria
This trial is for adults over 18 who have recently been diagnosed with HIV and are starting medical care for it. Participants must speak and read English well enough to follow the study procedures and have access to a telephone. People with cognitive impairments cannot join.Inclusion Criteria
I am 18 years old or older.
Treatment Details
The trial is testing Acceptance-Based Behavior Therapy (ABBT) against an Enhanced-Treatment-as-Usual (ETAU) control condition, aiming to improve commitment to medical care among new HIV patients. It's a randomized study, meaning participants are randomly assigned to one of the two groups.
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Acceptance-Based Behavior Therapy (ABBT)Experimental Treatment1 Intervention
The 2-session ABBT will be delivered in person at session 1 and by telephone at session 2.
Group II: Enhanced-Treatment-as-Usual (ETAU)Placebo Group1 Intervention
In addition to receiving treatment-as-usual at the clinic, ETAU participants will receive a 2-session program of HIV education.
Find a clinic near you
Research locations nearbySelect from list below to view details:
Brown UniversityProvidence, RI
Loading ...
Who is running the clinical trial?
Brown UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator